
Arrow-3
Israel's exo-atmospheric ballistic missile interceptor, now critically depleted by sustained Iranian salvos.
Last refreshed: 30 March 2026 · Appears in 1 active topic
Can Israel replenish Arrow-3 stocks fast enough to survive Iran's missile campaign?
Timeline for Arrow-3
Mentioned in: Hezbollah Missile Hits Tel Aviv Range
Iran Conflict 2026Interceptor Crisis Reaches Projected Depletion Window
Iran Conflict 2026Mentioned in: IDF Admits Air Defence Failures at Dimona and Arad
Iran Conflict 2026Mentioned in: Iran War Burns Through Pacific Missile Reserves
Iran Conflict 2026Arrow-3 stocks hit 81 per cent drain
Iran Conflict 2026What is Arrow-3?
Is Israel running out of Arrow-3 missiles?
Has Arrow-3 failed to intercept Iranian missiles?
Background
Arrow-3 is Israel's uppermost layer of air defence, designed to intercept Ballistic Missiles above the atmosphere during their mid-course phase. Jointly developed by the Israel Defense Forces (IDF) and the United States' Missile Defense Agency, it entered operational service in 2017. Built by Israel Aerospace Industries with Boeing as the US partner, it sits atop a layered shield alongside David's Sling for medium-range threats and Iron Dome for short-range rockets.
Arrow-3 faced its most demanding test during the 2026 Iran-Israel conflict. Iran's escalating use of one-tonne warheads and clustered salvos exposed the system's finite magazine: US officials told Semafor that Israel had informed Washington it was critically low on ballistic missile interceptors . Israel's cabinet approved NIS 2.6 billion in emergency procurement to address the shortage . Interceptor failures near Dimona confirmed the system was stretched .
The core tension is one of attrition. Each Arrow-3 interceptor costs an estimated $2-3 million; Iran's Ballistic Missiles cost a fraction of that. Sustained Iranian salvos have forced Israel to confront whether production rates can keep pace with expenditure, raising questions about the long-term viability of interceptor-led defence against a determined adversary with an asymmetric cost advantage.